Anti-Dilution Provisions: What Every Angel Investor Needs to Know
According to PitchBook's research , nearly 25 percent of all US venture rounds in 2024 were flat or down rounds — a decade high — making anti-dilution provisions more relevant than they have been sinc

Why Anti-Dilution Matters Right Now
A down round is when a company raises new capital at a lower valuation than the previous round. It happens. It happened at record rates in 2024. It's happening again in 2025, where 15.9 percent of venture-backed deals were down rounds as of mid-year, per PitchBook via Fortune , another decade high.
Anti-dilution provisions exist to partially offset the financial damage. When a down round happens, the company issues new shares at a lower price per share. Without anti-dilution protection, your earlier-purchased preferred shares become worth proportionally less. With anti-dilution protection, your conversion price adjusts downward , giving you more shares at conversion and partially restoring your ownership percentage.
In Q3 2024, 100 percent of deals tracked by Cooley LLP's Q3 2024 Venture Financing Report included broad-based weighted average anti-dilution protection. Zero deals used full ratchet. This was the first time in Cooley's reporting history every deal converged on one structure.
The Three Types: Full Ratchet, Broad-Based, Narrow-Based
Anti-dilution provisions come in three flavors. Each shifts the pain of a down round differently.
Full Ratchet , Maximum Protection, Maximum Founder Damage:
Example: You invest $500,000 at $1.00 per share in a Series A. You receive 500,000 preferred shares. Eighteen months later, a Series B closes at $0.50 per share. Under full ratchet, your conversion price resets entirely to $0.50. Your 500,000 preferred shares now convert into 1,000,000 common shares. You got double the shares. The founders absorbed the entire dilution. Their ownership percentage collapsed. Full ratchet is effective for the investor and destructive for everyone else. Zero deals used it in Q3 2024 , because it kills founding teams and makes companies uninvestable.
Broad-Based Weighted Average , The Market Standard:
The formula: New Conversion Price = Old Price × (A + B) / (A + C), where A equals fully diluted shares outstanding before the down round, B equals hypothetical shares the new money would buy at the old price, and C equals actual new shares issued.
Example: 500,000 preferred shares at $1.00. Company has 2,000,000 fully diluted shares before the Series B. New round raises $500,000 at $0.50 per share, issuing 1,000,000 new shares. New Conversion Price = $1.00 × (2,000,000 + 500,000) / (2,000,000 + 1,000,000) = $1.00 × 2,500,000 / 3,000,000 = $0.833. Your conversion price drops from $1.00 to $0.833. You get approximately 600,000 shares instead of 500,000. Partial protection. Founders keep more equity. Company stays investable.
Narrow-Based Weighted Average , Weaker Protection:
Same formula, but the denominator uses only preferred shares instead of all fully diluted shares. This gives investors less protection than broad-based. You will rarely see this in institutional deals. When you do, it usually signals a company in distress negotiating from a position of weakness.
The SAFE Trap: Why Most Angel Investments Have Zero Protection
Here is the part that trips up most angel investors: SAFEs have no anti-dilution protection.
A SAFE is not equity. It is a convertible instrument that converts to equity at a future priced round. SAFEs do not carry anti-dilution provisions. When the Series A or Series B prices, your SAFE converts at that price , no adjustment, no extra shares for down-round pain.
Many angels confuse the MFN (Most Favored Nation) clause in a SAFE with anti-dilution. They are not the same. An MFN clause means: if a subsequent SAFE is issued with better terms (lower cap, higher discount) than yours, you get to adopt those terms. The MFN clause applies to other SAFEs only , not to equity rounds. If the Series A is a down round priced below your SAFE's cap, your SAFE converts at the Series A price with no adjustment. The MFN clause is irrelevant.
The Y Combinator SAFE documents are explicit about this. Read them before you invest. If anti-dilution protection matters to you, take preferred stock in the priced round. You cannot get that protection through a SAFE.
When Anti-Dilution Triggers: Real Examples
Klarna's 2022 down round went from $45.6 billion to $6.7 billion , an 85 percent collapse. Anti-dilution provisions triggered across multiple preferred series. Early investors got partial protection. Common stockholders (founders, employees) absorbed the uncushioned dilution. Klarna IPO'd in September 2025 on the NYSE at $15.1 billion , still 67 percent below the 2021 peak, but at least a recovery. Down-round investors who held recovered. The math worked because the company survived.
Instacart IPO'd at $9.9 billion, roughly 75 percent below its $39 billion peak private valuation. Anti-dilution triggered across multiple preferred series. Common stockholders bore the brunt. The pattern is consistent: preferred holders with anti-dilution get partial protection, common holders absorb the rest.
Pay-to-Play: The Provision That Can Strip Your Protection
Pay-to-play is the clause that says: if you do not participate pro-rata in the next financing round, you lose your anti-dilution protection. Your preferred stock converts to common. Cooley's Q4 2024 report found pay-to-play in 9.3 percent of deals , the highest rate in any Q4 on record.
If pay-to-play is in your term sheet and you cannot or will not write follow-on checks, you lose your anti-dilution protection in the next financing. You become a common shareholder. In a down round, that means you absorb the full dilution hit , no conversion price adjustment, no extra shares. Negotiate this provision out if you cannot commit to follow-on capital.
Should Angels Push for Anti-Dilution?
If you are taking preferred stock , which you should at $100,000-plus check sizes , anti-dilution is standard. Expect it. Every Series A in the current market includes it. Push for broad-based weighted average as your floor. Resist narrow-based.
If you are writing a $10,000 to $25,000 seed check via SAFE, accept that you have no anti-dilution protection. That is the price of the SAFE's simplicity and speed. If the investment thesis requires downside protection, SAFEs are the wrong instrument.
Anti-dilution does not protect you if the company fails. Your equity is worthless whether or not you have anti-dilution. It protects you only if the company survives a down round and eventually recovers. The investment still needs to be right. The clause just changes who absorbs the pain of a rough patch.
Read the NVCA model legal documents and study the Certificate of Incorporation before you sign. The anti-dilution mechanics are always in there. Knowing what you are signing is your first and most important protection.
Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.
Looking for investors?
Browse our directory of 750+ angel investor groups, VCs, and accelerators across the United States.
About the Author
Jeff Barnes, MBA